Tennessee ophthalmologists dispute legislation allowing ODs to use injectable anesthesia

Article

The Tennessee Academy of Ophthalmology (TNAO) is opposing a recently filed bill (SB220/HB555) that, as amended, would allow optometrists to inject local anesthesia into the tissue surrounding the eye in order to perform surgery.

Nashville, TN-The Tennessee Academy of Ophthalmology (TNAO) is opposing a recently filed bill (SB220/HB555) that, as amended, would allow optometrists to inject local anesthesia into the tissue surrounding the eye in order to perform surgery.

The legislation would expand optometrists’ scope of practice to allow them to inject anesthesia into the tissues surrounding the eyelid. Under the legislation, optometrists would be permitted to perform more advanced surgical procedures that require an injectable anesthetic.

“This legislation would create an unnecessary risk to patients and is a threat to the quality of surgical care in Tennessee,” said Ben Mahan, MD, president of the TNAO. “Anytime a needle is placed near the eye, there are serious risks to the patient that require clinical experience and expert judgment. A surgical error of just a few millimeters can result in a punctured eyeball and catastrophic vision loss.

“Whether it is injections to prepare for surgery or the surgery itself, patients have a right to know that the individual performing the procedure is a qualified medical doctor and surgeon,” Dr. Mahan said.

See the upcoming April issue of Optometry Times for deeper coverage on the Tennesee bill.

Read the original story

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.